Skin Clearance and Itch Relief in Black or African American Patients with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib: 140-Week Outcomes from Integrated Phase 3 Measure Up 1 and 2 Studies. J of Skin [Internet]. 2025 Nov. 10 [cited 2026 Apr. 20];9(6):s615. Available from: https://skin.dermsquared.com/skin/article/view/3873